| iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics L Seymour, J Bogaerts, A Perrone, R Ford, LH Schwartz, S Mandrekar, ... The Lancet Oncology 18 (3), e143-e152, 2017 | 2219 | 2017 |
| Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin E Maubec, P Petrow, I Scheer-Senyarich, P Duvillard, L Lacroix, J Gelly, ... Journal of Clinical Oncology 29 (25), 3419-3426, 2011 | 485 | 2011 |
| Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) CJ Rageth, EAM O’Flynn, K Pinker, RA Kubik-Huch, A Mundinger, ... Breast cancer research and treatment 174, 279-296, 2019 | 264 | 2019 |
| Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses I Thomassin-Naggara, E Poncelet, A Jalaguier-Coudray, A Guerra, ... JAMA network open 3 (1), e1919896-e1919896, 2020 | 227 | 2020 |
| Vacuum-assisted biopsies under MR guidance: results of 72 procedures C Malhaire, C El Khoury, F Thibault, A Athanasiou, P Petrow, L Ollivier, ... European radiology 20, 1554-1562, 2010 | 92 | 2010 |
| Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET) V Servois, P Mariani, C Malhaire, S Petras, S Piperno-Neumann, ... European Journal of Surgical Oncology (EJSO) 36 (2), 189-194, 2010 | 83 | 2010 |
| Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy F Mercier, F Dagbert, M Pocard, D Goéré, F Quenet, R Wernert, F Dumont, ... BJS open 3 (2), 195-202, 2019 | 58 | 2019 |
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin JB Delhorme, F Severac, G Averous, O Glehen, G Passot, N Bakrin, ... Journal of British Surgery 105 (6), 668-676, 2018 | 53 | 2018 |
| Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRI N Lassau, T Estienne, P de Vomecourt, M Azoulay, J Cagnol, G Garcia, ... Diagnostic and interventional imaging 100 (4), 199-209, 2019 | 50 | 2019 |
| Pelvic insufficiency fracture (PIF) incidence in patients treated with intensity-modulated radiation therapy (IMRT) for gynaecological or anal cancer: single-institution … L Bazire, H Xu, JP Foy, M Amessis, C Malhaire, K Cao, ... The British Journal of Radiology 90 (1073), 20160885, 2017 | 50 | 2017 |
| Digital breast tomosynthesis versus mammography and breast ultrasound: a multireader performance study F Thibault, C Dromain, C Breucq, CS Balleyguier, C Malhaire, L Steyaert, ... European radiology 23, 2441-2449, 2013 | 46 | 2013 |
| Multiparametric MRI and radiomics for the prediction of HER2-zero,-low, and-positive breast cancers T Ramtohul, L Djerroudi, E Lissavalid, C Nhy, L Redon, L Ikni, M Djelouah, ... Radiology 308 (2), e222646, 2023 | 44 | 2023 |
| The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry L Villeneuve, G Passot, O Glehen, S Isaac, F Bibeau, P Rousset, FN Gilly Orphanet journal of rare diseases 12, 1-9, 2017 | 42 | 2017 |
| Prospective evaluation of ultrafast breast MRI for predicting pathologic response after neoadjuvant therapies T Ramtohul, C Tescher, P Vaflard, J Cyrta, N Girard, C Malhaire, ... Radiology 305 (3), 565-574, 2022 | 36 | 2022 |
| A radiomics pipeline dedicated to Breast MRI: validation on a multi-scanner phantom study MJ Saint Martin, F Orlhac, P Akl, F Khalid, C Nioche, I Buvat, C Malhaire, ... Magnetic Resonance Materials in Physics, Biology and Medicine 34, 355-366, 2021 | 35 | 2021 |
| Innovative DIEP flap perfusion evaluation tool: qualitative and quantitative analysis of indocyanine green-based fluorescence angiography with the SPY-Q proprietary software N Girard, M Delomenie, C Malhaire, D Sebbag, A Roulot, A Sabaila, ... PLoS One 14 (6), e0217698, 2019 | 31 | 2019 |
| Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial M Rodrigues, G Vanoni, P Loap, C Dubot, E Timperi, M Minsat, L Bazire, ... Nature Communications 14 (1), 3698, 2023 | 28 | 2023 |
| Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma C Daveau, S Baulies, M Lalloum, M Bollet, B Sigal-Zafrani, X Sastre, ... British journal of cancer 110 (9), 2195-2200, 2014 | 28 | 2014 |
| Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate … E Guillot, C Vaysse, J Goetgeluck, MC Falcou, B Couturaud, A Fitoussi, ... The Breast 23 (2), 97-103, 2014 | 27 | 2014 |
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly: a case-controlled, multicenter study M Alyami, P Lundberg, V Kepenekian, D Goere, JM Bereder, S Msika, ... Annals of surgical oncology 23, 737-745, 2016 | 26 | 2016 |
fabien reyalInstitut Curie. Department of SurgeryVerified email at curie.fr
